Showing results (251-260 of 985) with videos related to
Sort By:
Pageof 99
Current Heart Failure Reports|October 17, 2015
Evolving Approaches to Genetic Evaluation of Specific CardiomyopathiesLoon Yee Louis Teo, Rocio T Moran, W H Wilson TangCardiovascular Diabetology|August 22, 2021
Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetesMarco Witkowski, Yuping Wu, Stanley L Hazen, et al.Journal of Personalized Medicine|June 28, 2023
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized MedicineSahana Aiyer, Emilia Kalutskaya, Arianne C Agdamag, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Successful medical management of isolated renal zygomycosis: case report and reviewD E Weng, W H Wilson, R Little, et al.Current Treatment Options in Cardiovascular Medicine|August 28, 2016
Practical Pharmacogenomic Approaches to Heart Failure TherapeuticsChayakrit Krittanawong, Amalia Namath, David E Lanfear, et al.Biological Psychiatry|December 15, 1996
A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophreniaC L Donnelly, J P McEvoy, W H Wilson, et al.Current Heart Failure Reports|February 25, 2017
Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical ImplicationsYoun-Hyun Kim, Petra Nijst, Kathryn Kiefer, et al.Journal of the American Academy of Dermatology|November 1, 1996
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alphaR Prussick, T D Horn, W H Wilson, et al.American Heart Journal|November 29, 2016
Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status IndexVichai Senthong, Yuping Wu, Stanley L Hazen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplantR Little, R E Wittes, D L Longo, et al.Pageof 99